Background/aim: The aims of the present study were to assess the relationship between the distance walked during the 6-min walk test (6MWT) and exercise capacity as determined by cardiopulmonary exercise testing (CPET) in patients with pulmonary arterial hypertension (PAH) and to investigate the prognostic value of the 6MWT in comparison to clinical parameters of CPET and echocardiography findings
Objective: To investigate the prognostic value of the 6-minute walking distance (6-MWD), transcutane...
International audienceObjectives Despite the wide use of the 6 min walk distance (6MWD), no study ha...
International audienceObjectives Despite the wide use of the 6 min walk distance (6MWD), no study ha...
Background/aim: The aims of the present study were to assess the relationship between the distance w...
Background: Exercise-induced pulmonary arterial hypertension (EIPAH) is associated with reduced peak...
ABSTRACT: The 6-min walk test (6MWT) is commonly used to evaluate exercise capacity in patients with...
Background To ensure effective monitoring of pulmonary arterial hypertension (PAH), a simple, rel...
<p>Correlation between the six-minute walk test (6MWT) distance and the mean daily steps in patients...
Introduction: Exercise variables determined in patients with pulmonary arterial hypertension (PAH) a...
The importance of studying the pathophysiological bases and clinical correlates of exercise limitati...
ABSTRACT: Patients with pulmonary arterial hypertension (PAH) exhibit a limited increase in stroke v...
exercise test. The 6-minute walk test (T6) is used to assess cardiopulmonary diseases due to its pro...
Patients with pulmonary arterial hypertension who achieve a six-minute walk distance of 380-440 m ma...
Objective: To investigate the prognostic value of the 6-minute walking distance (6-MWD), transcutane...
Objective: To investigate the prognostic value of the 6-minute walking distance (6-MWD), transcutane...
Objective: To investigate the prognostic value of the 6-minute walking distance (6-MWD), transcutane...
International audienceObjectives Despite the wide use of the 6 min walk distance (6MWD), no study ha...
International audienceObjectives Despite the wide use of the 6 min walk distance (6MWD), no study ha...
Background/aim: The aims of the present study were to assess the relationship between the distance w...
Background: Exercise-induced pulmonary arterial hypertension (EIPAH) is associated with reduced peak...
ABSTRACT: The 6-min walk test (6MWT) is commonly used to evaluate exercise capacity in patients with...
Background To ensure effective monitoring of pulmonary arterial hypertension (PAH), a simple, rel...
<p>Correlation between the six-minute walk test (6MWT) distance and the mean daily steps in patients...
Introduction: Exercise variables determined in patients with pulmonary arterial hypertension (PAH) a...
The importance of studying the pathophysiological bases and clinical correlates of exercise limitati...
ABSTRACT: Patients with pulmonary arterial hypertension (PAH) exhibit a limited increase in stroke v...
exercise test. The 6-minute walk test (T6) is used to assess cardiopulmonary diseases due to its pro...
Patients with pulmonary arterial hypertension who achieve a six-minute walk distance of 380-440 m ma...
Objective: To investigate the prognostic value of the 6-minute walking distance (6-MWD), transcutane...
Objective: To investigate the prognostic value of the 6-minute walking distance (6-MWD), transcutane...
Objective: To investigate the prognostic value of the 6-minute walking distance (6-MWD), transcutane...
International audienceObjectives Despite the wide use of the 6 min walk distance (6MWD), no study ha...
International audienceObjectives Despite the wide use of the 6 min walk distance (6MWD), no study ha...